MicroRNAs as Regulators and Biomarkers of Platelet Function and Activity in Coronary Artery Disease

Thromb Haemost. 2019 Oct;119(10):1563-1572. doi: 10.1055/s-0039-1693702. Epub 2019 Aug 17.

Abstract

Microribonucleic acids (miRs) are small, noncoding ribonucleic acids (RNAs), which play an important role in the regulation of platelet function and activity. Several studies proposed a mechanistic role of platelet-related miRs in the pathophysiology of coronary artery disease (CAD) and atherothrombosis. Circulating, platelet-related miRs have been proposed as diagnostic, prognostic, as well as treatment response biomarkers in CAD and acute coronary syndrome (ACS). In this review, we summarize recent studies on the role of platelet-related miRs in the regulation of platelet function and activity. Furthermore, we review the studies investigating the role of platelet-related miRs as biomarkers in patients with CAD and ACS.

Publication types

  • Review

MeSH terms

  • Acute Coronary Syndrome / blood*
  • Acute Coronary Syndrome / diagnosis
  • Biomarkers / blood*
  • Blood Platelets / cytology*
  • Coronary Artery Disease / blood*
  • Coronary Artery Disease / diagnosis
  • Drug Resistance
  • Humans
  • MicroRNAs / blood*
  • Myocardial Infarction / blood
  • Myocardial Infarction / diagnosis
  • Platelet Aggregation Inhibitors / pharmacology
  • Platelet Function Tests
  • Prognosis

Substances

  • Biomarkers
  • MicroRNAs
  • Platelet Aggregation Inhibitors